ES8602409A1 - Metodo de preparar agentes para tratar enfermedades neurologicas y similares - Google Patents

Metodo de preparar agentes para tratar enfermedades neurologicas y similares

Info

Publication number
ES8602409A1
ES8602409A1 ES532873A ES532873A ES8602409A1 ES 8602409 A1 ES8602409 A1 ES 8602409A1 ES 532873 A ES532873 A ES 532873A ES 532873 A ES532873 A ES 532873A ES 8602409 A1 ES8602409 A1 ES 8602409A1
Authority
ES
Spain
Prior art keywords
aging
pharmaceutical composition
neurological disease
choline
treating neurological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532873A
Other languages
English (en)
Spanish (es)
Other versions
ES532873A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of ES532873A0 publication Critical patent/ES532873A0/es
Publication of ES8602409A1 publication Critical patent/ES8602409A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES532873A 1983-05-16 1984-05-15 Metodo de preparar agentes para tratar enfermedades neurologicas y similares Expired ES8602409A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49520283A 1983-05-16 1983-05-16

Publications (2)

Publication Number Publication Date
ES532873A0 ES532873A0 (es) 1985-12-16
ES8602409A1 true ES8602409A1 (es) 1985-12-16

Family

ID=23967687

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532873A Expired ES8602409A1 (es) 1983-05-16 1984-05-15 Metodo de preparar agentes para tratar enfermedades neurologicas y similares

Country Status (8)

Country Link
EP (1) EP0125900B1 (cg-RX-API-DMAC7.html)
JP (1) JPS60214734A (cg-RX-API-DMAC7.html)
AT (1) ATE45672T1 (cg-RX-API-DMAC7.html)
CA (1) CA1228301A (cg-RX-API-DMAC7.html)
DE (1) DE3479477D1 (cg-RX-API-DMAC7.html)
ES (1) ES8602409A1 (cg-RX-API-DMAC7.html)
GR (1) GR79973B (cg-RX-API-DMAC7.html)
IL (1) IL71819A (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657013B1 (fr) * 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1114295A (en) * 1977-11-02 1981-12-15 John H. Growdon Process and composition for treating disorders by administering choline or a compound that dissociates to choline
DE2967257D1 (en) * 1978-04-24 1984-11-22 Massachusetts Inst Technology Composition for regulating dopamine or norepinephrine levels in neuronal synapses
DE2962429D1 (en) * 1978-04-24 1982-05-19 Massachusetts Inst Technology A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
US4221784A (en) * 1979-04-05 1980-09-09 Massachusetts Institute Of Technology Process and composition for treating disorders by administering lecithin
DE2915433A1 (de) * 1979-04-17 1980-10-30 Christensen Plantorgan Werk Verwendung von physiologisch vertraeglichen methyldonatoren
US4397866A (en) * 1979-05-07 1983-08-09 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord

Also Published As

Publication number Publication date
EP0125900A1 (en) 1984-11-21
DE3479477D1 (en) 1989-09-28
IL71819A0 (en) 1984-09-30
JPH0141124B2 (cg-RX-API-DMAC7.html) 1989-09-04
IL71819A (en) 1987-12-31
ES532873A0 (es) 1985-12-16
EP0125900B1 (en) 1989-08-23
JPS60214734A (ja) 1985-10-28
GR79973B (cg-RX-API-DMAC7.html) 1984-10-31
ATE45672T1 (de) 1989-09-15
CA1228301A (en) 1987-10-20

Similar Documents

Publication Publication Date Title
AU1943388A (en) 3-indolepyruvic acid derivatives and pharmaceutical use thereof
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
GB2128088B (en) Oral mopidamol preparations
YU209288A (en) Process for producing compound for treating, which contains azelastin for use in nose and/or eye
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
HUT63182A (en) Process for treating or preventing autoimmune uveoretinitis in mammals
ES2139081T3 (es) Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
DE3479477D1 (en) A pharmaceutical composition for use in treating neurological disease or aging
DE3774291D1 (de) Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen.
ES2038847T3 (es) Proceso para la preparacion de una composicion farmacutica conteniendo zidovudine e inosiplex para el tratamiento del sida y sindromes afines.
DE2966809D1 (en) 3,4-diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
KR880004810A (ko) 소화성 궤양 치료제
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
DE3878154D1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
NO894083D0 (no) Framsoeytiske blandinger for behandling av adrenoleukodystrophy.
EP0144489A3 (en) Cerebral and peripheral antihypoxidoticum
ATE153859T1 (de) Somatotropin zur erhoehung der reproduktiven leistung in rinder
DE69002743D1 (de) Verfahren zur verbesserung der ventilation waehrend des schlafes und behandlung von ventilationsabnormalitaeten, die mit dem schlaf verbunden sind.